KAUR, M. and MISRA, S. (2025) “REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD)”, International Journal of Current Pharmaceutical Research, 17(3), pp. 7–9. doi: 10.22159/ijcpr.2025v17i3.55038.